At a glance
- Originator Chugai Pharmaceutical
- Class Uricosurics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gout
Most Recent Events
- 15 Nov 2006 Discontinued for Gout in Japan (PO)
- 08 Sep 2000 No-Development-Reported for Gout in Japan (PO)